• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

I brazilian position paper on antihypertensive drug combination.

作者信息

Póvoa Rui, Barroso Weimar Sebba, Brandão Andrea A, Jardim Paulo Cesar Veiga, Barroso Oswaldo, Passarelli Oswaldo, Gemelli João Roberto, Feitosa Audes, Jardim Thiago Veiga, Carneiro Sergio Baiocchi, Amodeo Celso, Moreira Filho Osni, Nogueira Armando da Rocha, Morais Nelson Siqueira de, Scala Luiz Cesar Nazário, Gonzaga Carolina, Souza Dilma do Socorro Moraes de, Paiva Annelise Machado Gomes de, Malachias Marcus Vinicius Bolivar, Mion Décio, Mota-Gomes Marco Antônio, Barbosa Eduardo Costa Duarte, Sousa Marcio Gonçalves de, Bianco Henrique Tria, Fonseca Francisco Antonio Helfenstein, Kalil Marcio, Miranda Roberto Dischinger, Uehara Carlos André, Sanjuliani Antônio Felipe

出版信息

Arq Bras Cardiol. 2014 Mar;102(3):203-10. doi: 10.5935/abc.20140023.

DOI:10.5935/abc.20140023
PMID:24714792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3987325/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000b/3987325/b1e8a7466327/abc-102-03-0203-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000b/3987325/b1e8a7466327/abc-102-03-0203-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000b/3987325/b1e8a7466327/abc-102-03-0203-g01.jpg

相似文献

1
I brazilian position paper on antihypertensive drug combination.巴西关于抗高血压药物联合使用的立场文件。 （注：原英文表述不太准确规范，推测可能想表达的是 “The Brazilian Position Paper on Antihypertensive Drug Combination” 之类的，但按照要求仅按给定原文翻译）
Arq Bras Cardiol. 2014 Mar;102(3):203-10. doi: 10.5935/abc.20140023.
2
A feared combination: Hypertension and chronic kidney disease.一种令人担忧的组合：高血压与慢性肾病。
J Clin Hypertens (Greenwich). 2019 Jan;21(1):102-104. doi: 10.1111/jch.13432. Epub 2018 Nov 14.
3
The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence.美国心脏病学会/美国心脏协会与欧洲心脏病学会/欧洲高血压学会高血压指南：各具特色的不同版本。
Am J Hypertens. 2019 Jul 17;32(8):705-708. doi: 10.1093/ajh/hpz092.
4
[Treatment of complicated arterial hypertension].
Ter Arkh. 1982;54(11):138-48.
5
Optimal blood pressure control in high-risk groups: are the guidelines letting us down?
South Med J. 2008 Sep;101(9):884-5. doi: 10.1097/SMJ.0b013e318180439f.
6
[Practice guidelines for therapy of patients with hypertension].
Nihon Naika Gakkai Zasshi. 2002 Mar 10;91(3):962-72.
7
[Should drug treatment be started with monotherapy or combination therapy for patients with hypertension].
Nihon Rinsho. 2006 Aug;64 Suppl 6:254-7.
8
Hypertension 2010: what was new for the cardiologist?高血压 2010：心脏病学家的新发现？
Expert Opin Pharmacother. 2010 Nov;11(16):2579-97. doi: 10.1517/14656566.2010.513972.
9
Risk factors and differential antihypertensive therapies.危险因素与降压治疗差异
Acta Med Austriaca. 1995;22(3):45-7.
10
Starting Antihypertensive Drug Treatment With Combination Therapy: Controversies in Hypertension - Pro Side of the Argument.起始联合治疗的抗高血压药物治疗：高血压争议——正方观点
Hypertension. 2021 Mar 3;77(3):800-805. doi: 10.1161/HYPERTENSIONAHA.120.12857. Epub 2021 Feb 10.

引用本文的文献

1
Antihypertensive Effect of New Agonist of Adenosine Receptor in Spontaneously Hypertensive Rats.新型腺苷受体激动剂在自发性高血压大鼠中的降压作用。
Arq Bras Cardiol. 2024 Apr 5;121(2):e20230405. doi: 10.36660/abc.20230405. eCollection 2024.
2
Treated Hypertensive Patients Assessed by Home Blood Pressure Telemonitoring. TeleMRPA Study.家庭血压远程监测评估的高血压患者。TeleMRPA 研究。
Arq Bras Cardiol. 2021 Sep;117(3):520-527. doi: 10.36660/abc.20200073.
3
Brazilian Guidelines of Hypertension - 2020.《巴西高血压指南 - 2020》

本文引用的文献

1
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理指南：欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理特别工作组
Eur Heart J. 2013 Jul;34(28):2159-219. doi: 10.1093/eurheartj/eht151. Epub 2013 Jun 14.
2
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.阿利克仑治疗 2 型糖尿病的心血管和肾脏终点试验。
N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.
3
Arq Bras Cardiol. 2021 Mar;116(3):516-658. doi: 10.36660/abc.20201238.
4
Brazilian Position Statement on Resistant Hypertension - 2020.《巴西2020年难治性高血压立场声明》
Arq Bras Cardiol. 2020 May-Jun;114(3):576-596. doi: 10.36660/abc.20200198.
5
First-line combination therapy versus first-line monotherapy for primary hypertension.原发性高血压的一线联合治疗与一线单一疗法对比
Cochrane Database Syst Rev. 2020 Feb 6;2(2):CD010316. doi: 10.1002/14651858.CD010316.pub3.
6
Compliance with the Prescription of Antihypertensive Medications and Blood Pressure Control in Primary Care.基层医疗中抗高血压药物处方的依从性与血压控制
Arq Bras Cardiol. 2017 Feb;108(2):135-142. doi: 10.5935/abc.20170009. Epub 2017 Feb 13.
7
First-line combination therapy versus first-line monotherapy for primary hypertension.一线联合治疗与一线单药治疗原发性高血压的比较
Cochrane Database Syst Rev. 2017 Jan 13;1(1):CD010316. doi: 10.1002/14651858.CD010316.pub2.
Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies.
高血压左心室肥厚的患病率：超声心动图研究的更新综述。
J Hum Hypertens. 2012 Jun;26(6):343-9. doi: 10.1038/jhh.2011.104. Epub 2011 Nov 24.
4
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期（1至3期）非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
5
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.美国心脏病学会基金会/美国心脏协会2011年老年人高血压专家共识文件：美国心脏病学会基金会临床专家共识文件特别工作组报告，该报告由美国神经病学学会、美国老年医学会、美国预防心脏病学会、美国高血压学会、美国肾脏病学会、黑人心脏病学家协会以及欧洲高血压学会共同合作制定。
J Am Soc Hypertens. 2011 Jul-Aug;5(4):259-352. doi: 10.1016/j.jash.2011.06.001.
6
Hypertension management 2011: optimal combination therapy.2011 年高血压管理：最佳联合治疗。
Eur Heart J. 2011 Oct;32(20):2499-506. doi: 10.1093/eurheartj/ehr177. Epub 2011 Jun 22.
7
Combination therapy in hypertension.高血压的联合治疗。
J Clin Hypertens (Greenwich). 2011 Mar;13(3):146-54. doi: 10.1111/j.1751-7176.2010.00397.x. Epub 2010 Dec 10.
8
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.在高血压成年患者中使用奥美沙坦酯、苯磺酸氨氯地平与氢氯噻嗪三联治疗的多中心、随机、双盲、12 周、平行分组研究（TRINITY）。
Clin Ther. 2010 Jul;32(7):1252-69. doi: 10.1016/j.clinthera.2010.07.008.
9
Optimizing blood pressure control through the use of fixed combinations.通过使用固定复方制剂优化血压控制。
Vasc Health Risk Manag. 2010 May 25;6:321-5. doi: 10.2147/vhrm.s9989.
10
Combination therapy in hypertension.高血压的联合治疗
J Am Soc Hypertens. 2010 Jan-Feb;4(1):42-50. doi: 10.1016/j.jash.2010.02.005.